Methazolamide
Methazolamide
Definition
A sulfonamide derivate and carbonic anhydrase inhibitor with potential antineoplastic activity. Methazolamide inhibits tumor-associated carbonic anhydrase IX (CAIX), which may result in increased cell death in hypoxic tumors. As a hypoxia-inducible transmembrane glycoprotein, CAIX catalyzes the rapid interconversion of carbon dioxide and water into carbonic acid, protons, and bicarbonate ions, helping to maintain acidification of the tumor microenvironment and enhance resistance to cytotoxic therapy in some hypoxic tumors.
Also known as Glauctabs, METHAZOLAMIDE, MZM, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-acetamide, Neptazane — per NCIT
Also identified as
- ATC S01EC05 per RXNORM
- NCIT NCIT:C61318 per NCIT
- SCTID 392575007 per RXNORM
- SCTID 53052005 per RXNORM
- UNII W733B0S9SD per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Angle-closure glaucoma | may treat | MEDRT · Public domain (U.S. Government work) |
| Open-angle glaucoma | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Camera-type eye | may treat a disease of this organ | DERIVED · CC BY 4.0 |
1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.